Latest Information Update: 04 Sep 2000
At a glance
- Originator Roche
- Class Antibacterials; Penicillins
- Mechanism of Action Beta lactamase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gram-negative infections
Most Recent Events
- 04 Sep 2000 Discontinued-Preclinical for Gram-negative infections in Switzerland (Unknown route)